Literature DB >> 20959890

Antibiotics: MRSA prevention measures in German hospitals: results of a survey among hospitals, performed as part of the MRSA-KISS module.

Iris F Chaberny1, Anne Wriggers, Michael Behnke, Petra Gastmeier.   

Abstract

BACKGROUND: In this study, we investigated the measures currently being taken in German hospitals to prevent infection with methicillin-resistant strains of Staphylococcus aureus (MRSA). To this end, we circulated a questionnaire among hospitals participating in the MRSA-KISS module. "KISS" in the name of this project stands for "hospital infection surveillance system" (in German, Krankenhaus-Infektions-Surveillance-System).
METHODS: The questionnaire was sent to all MRSA-KISS participants. A study doctor visited a representative sample of hospitals to validate the responses. The study doctor checked the questionnaire responses with a systematic on-site interview of the contact person in each hospital, then evaluated the information contained in them by recording all of the MRSA patients who were present in the hospital on the day of the visit in a point-prevalence study (PPS).
RESULTS: All 134 participants filled out the questionnaire. The screening of patients at risk on admission is an established part of the clinical routine in all of the surveyed hospitals, as are MRSA decolonization procedures. These preventive measures have been recommended for routine use in Germany by the Robert Koch Institute (RKI, the German counterpart of the Centers for Disease Control and Prevention). The surveyed hospitals also used further preventive strategies, including, for example, an alerting system for the identification, upon hospital admission, of patients with a known history of MRSA positivity (72%); pre-admission screening of all patients (13%); universal screening on admission in some hospital wards (19%); and the prophylactic isolation of patients suspected of having MRSA with pending microbiological test results (21%). 35 hospitals were visited for validation. Most of the responses in each hospital were internally consistent and adequately reflected the real situation on site. Less consistency was seen in responses regarding the detection of MRSA by clinical testing and the measures that were taken after MRSA was detected.
CONCLUSION: The surveyed hospitals are, in fact, implementing many of the RKI's recommendations, as well as other preventive measures against MRSA.

Entities:  

Mesh:

Year:  2010        PMID: 20959890      PMCID: PMC2956199          DOI: 10.3238/arztebl.2010.0631

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  9 in total

1.  Methicillin-Resistant Staphylococcus aureus Infections.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-10       Impact factor: 3.725

2.  Antimicrobial drug use and infection control practices associated with the prevalence of methicillin-resistant Staphylococcus aureus in European hospitals.

Authors:  F M MacKenzie; J Bruce; M J Struelens; H Goossens; J Mollison; I M Gould
Journal:  Clin Microbiol Infect       Date:  2007-03       Impact factor: 8.067

3.  Challenges of implementing national guidelines for the control and prevention of methicillin-resistant Staphylococcus aureus colonization or infection in acute care hospitals in the Republic of Ireland.

Authors:  Fidelma Fitzpatrick; Fiona Roche; Robert Cunney; Hilary Humphreys
Journal:  Infect Control Hosp Epidemiol       Date:  2009-03       Impact factor: 3.254

4.  [Hand hygiene and campaigns].

Authors:  I F Chaberny; I Möller; K Graf
Journal:  Pneumologie       Date:  2009-03-02

5.  Development of a surveillance system for methicillin-resistant Staphylococcus aureus in German hospitals.

Authors:  Iris F Chaberny; Dorit Sohr; Henning Rüden; Petra Gastmeier
Journal:  Infect Control Hosp Epidemiol       Date:  2007-03-15       Impact factor: 3.254

6.  [Clean hands campaign: no chance for healthcare associated infections].

Authors:  Christiane Reichardt; Maria Eberlein-Gonska; Matthias Schrappe; Petra Gastmeier
Journal:  Anasthesiol Intensivmed Notfallmed Schmerzther       Date:  2008-10-28       Impact factor: 0.698

Review 7.  Hand hygiene for the prevention of nosocomial infections.

Authors:  Günter Kampf; Harald Löffler; Petra Gastmeier
Journal:  Dtsch Arztebl Int       Date:  2009-10-02       Impact factor: 5.594

8.  Safety of patients isolated for infection control.

Authors:  Henry Thomas Stelfox; David W Bates; Donald A Redelmeier
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

9.  Methicillin-resistant Staphylococcus aureus in Europe, 1999-2002.

Authors:  Edine W Tiemersma; Stef L A M Bronzwaer; Outi Lyytikäinen; John E Degener; Paul Schrijnemakers; Nienke Bruinsma; Jos Monen; Wolfgang Witte; Hajo Grundman
Journal:  Emerg Infect Dis       Date:  2004-09       Impact factor: 6.883

  9 in total
  5 in total

Review 1.  The epidemiology of methicillin-resistant Staphylococcus aureus (MRSA) in Germany.

Authors:  Robin Köck; Alexander Mellmann; Frieder Schaumburg; Alexander W Friedrich; Frank Kipp; Karsten Becker
Journal:  Dtsch Arztebl Int       Date:  2011-11-04       Impact factor: 5.594

2.  Antibiotic stewardship in Germany: a cross-sectional questionnaire survey of 355 intensive care units.

Authors:  F Maechler; F Schwab; C Geffers; E Meyer; R Leistner; P Gastmeier
Journal:  Infection       Date:  2013-10-18       Impact factor: 3.553

3.  [Evidence-based antibiotic prophylaxis in general and visceral surgery].

Authors:  P Knebel; M A Weigand; M W Büchler; C M Seiler
Journal:  Chirurg       Date:  2011-03       Impact factor: 0.955

Review 4.  MRSA prevalence in European healthcare settings: a review.

Authors:  Madeleine Dulon; Frank Haamann; Claudia Peters; Anja Schablon; Albert Nienhaus
Journal:  BMC Infect Dis       Date:  2011-05-20       Impact factor: 3.090

5.  The quality of antimicrobial prescribing in acute care hospitals: results derived from a national point prevalence survey, Germany, 2016.

Authors:  Seven Johannes Sam Aghdassi; Frank Schwab; Sonja Hansen; Luis Alberto Peña Diaz; Michael Behnke; Petra Gastmeier; Tobias Siegfried Kramer
Journal:  Euro Surveill       Date:  2019-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.